IB Acquisition Corp. (IBAC): Total Assets
$17.13M
As of 2025-09-30
$8.52M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $17.13M | -85.7% | 2025-12-29, Balance as of period end |
| 2024-09-30 | $119.80M | n/m | 2025-12-29, Balance as of period end |
| 2023-09-30 | $52.6K | n/a | 2024-12-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| IB Acquisition Corp. (IBAC) | 2025-09-30 | $17.13M | -85.7% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $10.96M | +68.3% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $9.53M | +1.9% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $44.58M | +6.9% |
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $2.15M | -42.3% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| Absci Corp (ABSI) | 2025-12-31 | $216.30M | +1.3% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $300.91M | -7.6% |
Compare IBAC, BIAF, ISPC, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗